NOV Mono expands operation in Germany
Pumps specialist aims to grow Mono Universal Parts across Europe
Svetla Laskova will be located in Berlin and Werner Potrafke will be working near Bochum. Both have language skills and sales and business development experience in the industrial and engineering sectors.
According to Martyn Turner, Universal Parts product manager at Mono, there is a significant market for progressing cavity (PC) pumps in Germany and until recently buyers have had to purchase replacement parts from the OEM.
‘Mono manufactures a range of Universal Parts designed for use in other branded PC pumps and these two new appointments will help us to promote the benefits of the brand and our PC pump technology to the waste water market in Germany,’ he said.
The full range of Mono Universal Parts includes rotors, stators, coupling rods, shafts, pins/bushes, seals and drive train assemblies for use in Seepex, Netzsch, PCM, Allweiler, Robbins & Myers, Bornemann and Orbit pumps.
Based in Manchester, UK, NOV Mono Group has more than 700 authorised distributors worldwide and employs around 750 people.
You may also like
Manufacturing
etherna's mRNA and LNP platforms advance Dropshot Therapeutics' renal disease programme to clinical stage
etherna has announced that partner Dropshot Therapeutics has validated its platforms in preclinical renal disease research and will now progress to IND-enabling studies, with etherna providing GMP manufacturing support ahead of planned Phase I clinical trials in 2027
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
From bespoke to scalable: closing the manufacturing gap in advanced therapeutics
Dr Kevin Robinson (KSR) spoke to Cytiva’s Nicolas Pivet (NP), Vice President of Manufacturing and Digital Solutions, to find out how digitalisation and scalable manufacturing platforms are shaping the next phase of advanced therapeutics
Manufacturing
Piramal Pharma Solutions announces partnership with Botanix to support drug substance development
Piramal Pharma Solutions has entered into an agreement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited, to support the development and commercial supply of Sofdra. Sofdra is the first and only FDA-approved new chemical entity (NCE) for the treatment of primary axillary hyperhidrosis. Through this partnership, Piramal Pharma Solutions will leverage the strength of its North American drug substance facilities to support robust, consistent patient access to Sofdra
Manufacturing
ProtaGene and Merck partner to deliver end-to-end biologics testing
The duo will combine ProtaGene's early-stage biologics expertise with Merck's BioReliance GMP testing infrastructure, offering biopharmaceutical customers an integrated testing solution across the full drug development lifecycle